Contortrostatin, a Snake Venom Disintegrin, Inhibits β1 Integrin-mediated Human Metastatic Melanoma Cell Adhesion and Blocks Experimental Metastasis

Cancer Research

Volumn 54, Issue 18, 1994, Pages 4993-4998

  Trikha, Mohit ^a   De Clerck, Yves A ^a   Markland, Francis S ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; COLLAGEN TYPE 1; CONTORTROSTATIN; FIBRONECTIN; FIBRONECTIN RECEPTOR; INTEGRIN; IODINE 125; LAMININ; MONOCLONAL ANTIBODY; SCLEROPROTEIN; SNAKE VENOM; UNCLASSIFIED DRUG; VITRONECTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL ADHESION; CONTROLLED STUDY; DOSE RESPONSE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUNG METASTASIS; MASS SPECTROMETRY; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION; PROTEIN PURIFICATION; SCATCHARD PLOT;

ANIMAL; ANTIGENS, CD29; CELL ADHESION; DISINTEGRINS; HUMAN; INTEGRINS; LUNG NEOPLASMS; MELANOMA; MICE; MICE, SCID; PEPTIDES; SNAKE VENOMS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028111866     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Hynes, R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell, 69: 11-25, 1992.
2. Smyth, S.S. Joneckis, C.C. and Parise, L.V. Regulation of vascular integrins. Blood, 81: 2827-2843, 1993.
3. Cheresh, D.A. Structural and biologic properties of integrin-mediated cell adhesion. Clin. Lab. Med. 12: 217-236, 1992.
4. Ruoslahti, E. The Walter Herbert lecture. Control of cell motility and tumour invasion by extracellular matrix interactions. Br. J. Cancer, 66: 239-242, 1992.
5. Felding-Habermann, B. Mueller, B.M. Romerdahl, C.A. and Cheresh, D.A. Involvement of integrin a v gene expression in human melanoma tumorigenicity. J. Clin. Invest. 89: 2018-2022, 1992.
6. Felding-Habermann, B. Ruggeri, Z.M. and Cheresh, D.A. Distinct biological consequences of integrin αβ3-mediated melanoma cell adhesion to fibrinogen and its plasmic fragments. J. Biol. Chem. 267: 5070-5077, 1992.
7. Marshall, J.F. Nesbitt, S.A. Helfrich, M.H. Horton, M.A. Polakova, K. and Hart, I.R. Integrin expression in human melanoma cell lines: heterogeneity of vitronectin receptor composition and function. Int. J. Cancer, 49: 924-931, 1991.
8. Seftor, R.E.B. Seftor, E.A. Stetler-Stevenson, W.G. and Hendrix, M.J.C. The 72 kDa type IV collagenase is modulated via differential expression of αvβ3 and α5β1, integrins during human melanoma cell invasion. Cancer Res. 53: 3411-3415, 1993.
9. Huang, T.F. Holt, J.C. Lukasiewicz, H. and Niewiarowski, S. Trigramin: a low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein Ilb-IIIa complex. J. Biol. Chem. 262: 16157-16163, 1987.
10. Scarborough, R.M. Rose, J.W. Naughton, M.A. Phillips, D.R. Nannizzi, L. Arfsten, A. Campbell, A.M. and Charo, I.F. Characterization of the integrin specificities of disintegrins isolated from American pit viper venoms. J. Biol. Chem. 268: 1058-1065, 1993.
11. Gan, Z.R. Gould, R.J. Jacobs, J.W. Friedman, P.A. and Polokoff, M.A. Echistatin: a potent platelet aggregation inhibitor from the venom of the viper, Echis carinatus. J. Biol. Chem. 263: 19827-19832, 1988.
12. Chao, B.H. Jakubowski, J.A. Savage, B. Chow, E.P. Marzec, U.M. Harker, L.A. and Maraganore, J.M. Agkistrodon piscivorus piscivorus platelet aggregation inhibitor: a potent inhibitor of platelet activation. Proc. Natl. Acad. Sci. USA, 86: 8050-8054, 1989.
13. Williams, J. Rucinski, B. Holt, J. and Niewiarowski, S. Elegantin and albolabrin purified peptides from viper venoms: homologies with the RGDS domain of fibrinogen and von Willebrand factor. Biochim. Biophys. Acta, 1039: 81-89, 1990.
14. Scarborough, R.M. Rose, J.W. Hsu, M.A. Phillips, D.R. Fried, V.A. Campbell, A.M. Nannizzi, L. and Charo, I.F. Barbourin. A GPIIb-IIIa specific integrin antagonist from the venom of Sistrurus m. barbouri. J. Biol. Chem. 266: 9359-9362, 1991.
15. Huang, T.F. Sheu, J.R. Teng, C.M. Chen, S.W. and Liu, C.S. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein Ilb-IIIa complex. J. Biochem. 709: 328-334, 1991.
16. Gould. R.J. Polokoff, M.A. Friedman, P.A. Huang, T.F. Holt, J.C. Cook, J.J. and Niewiarowski, S. Disintegrins: a family of integrin inhibitory proteins from viper venoms. Proc. Soc. Exp. Biol. Med. 795: 168-171, 1990.
17. Williams, J.A. Disintegrins: RGD-containing proteins which inhibit cell/matrix interactions (adhesion) and cell/cell interactions (aggregation) via the integrin receptors. Pathol. Biol. 40: 813-821, 1992.
18. Trikha, M. Rote, W.E. Mancly, P.J. Lucchesi, B.R. and Markland, F.S. Purification and characterization of platelet aggregation inhibitors from snake venoms. Thromb. Res. 73: 39-52, 1994.
19. Yasuda, T. Gold, H.K. Leinbach, R.C. Yaoita, H. Fallon, J.T. Guerrero, L. Napier, M.A. Bunting, S. and Collen, D. Kistrin, a polypeptide platelet GPIIb/IIIa receptor antagonist, enhances and sustains coronary arterial thrombolysis with recombinant tissue-type plasminogen activator in a canine preparation. Circulation, 83: 1038-1047, 1991.
20. Holahan, M.A. Mellott, M.J. Garsky, V.M. and Shebuski, R.J. Prevention of reocclusion following tissue type plasminogen activator-induced thrombolysis by the RGD-containing peptide, echistatin, in a canine model of coronary thrombosis. Pharmacology, 42: 340-348, 1991.
21. Shebuski, R.J. Stabilito, I.J. Sitko, G.R. and Polokoff, M.H. Acceleration of recombinant tissue-type plasminogen activator-induced thrombolysis and prevention of reocclusion by the combination of heparin and the Arg-Gly-Asp-containing peptide bitistatin in a canine model of coronary thrombosis. Circulation, 82: 169-177, 1990.
22. Mueller, B.M. Romerdahl, C.A. Trent, J.M. and Reisfeld, R.A. Suppression of spontaneous melanoma metastasis in scid mice with an antibody to the epidermal growth factor receptor. Cancer Res. 57: 2193-2198, 1991.
23. Akiyama, S.K. Yamada, S.S. Chen, W.T. and Yamada, K.M. Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization. J. Cell Biol. 709: 863-875, 1989.
24. Wayner, E.A. Orlando, R.A. and Cheresh, D.A. Integrins αvβ3 and αv/β5 contribute to cell attachment to vitronectin but differentially distribute on the cell surface. J. Cell Biol. 775: 919-929, 1991.
25. Friedman, M. Krull, L.H. and Cavins, J.F. The chromatographic determination of cystine and cysteine residues in proteins as S-β-(4-pyridylethyl)cysteine. J. Biol. Chem. 245: 3868-3871, 1970.
26. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65: 55-63, 1983.
27. Alvarez, O.A. Carmichael, D.F. and DeClerck, Y.A. Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases. J. Natl. Cancer Inst. 82: 589-595, 1990.
28. Kramer, R.H. Vu, M. Cheng, Y.F. and Ramos, D.M. Integrin expression in malignant melanoma. Cancer Metastasis Rev. 10: 49-59, 1991.
29. Wencel-Drake, J.D. Frelinger, A.L. III, Dieter, M.G. and Lam, S.C.T. Arg-Gly-Asp-dependent occupancy of GPIIb/IIIa by applaggin: evidence for internalization and cycling of a platelet integrin. Blood, 81: 62-69, 1993.
30. Knudsen, K.A. Tuszynski, G.P. Huang, T.F. and Niewiarowski, S. Trigramin, an RGD-containing peptide from snake venom, inhibits cell-substratum adhesion of human melanoma cells. Exp. Cell Res. 779: 42-49, 1988.
31. Soszka, T. Knudsen, K.A. Beviglia, L. Rossi, C. Poggi, A. and Niewiarowski, S. Inhibition of murine melanoma cell-matrix adhesion and experimental metastasis by albolabrin, an RGD-containing peptide isolated from the venom of Trimeresurus albolabris. Exp. Cell Res. 196: 6-12, 1991.
32. Rucinski, B. Niewiarowski, S. Holt, J.C. Soszka, T. and Knudsen, K.A. Batroxostatin, an Arg-Gly-Asp-containing peptide from Bothrops atrox, is a potent inhibitor of platelet aggregation and cell interaction with fibronectin. Biochim. Biophys. Acta, 1054: 257-262, 1990.
33. Sheu, J.R. Lin, C.H. Chung, J.L. Teng, C.M. and Huang, T.F. Triflavin, an Arg-Gly-Asp-containing antiplatelet peptide inhibits cell-substratum adhesion and melanoma cell-induced lung colonization. Jpn. J. Cancer Res. 83: 885-893, 1992.
34. Cardarelli, P.M. Yamagata, S. Ikuhiko, T. Gorcsan, F. Chiang, S.L. and Lobl, T. The collagen receptor a2 from MG-63 and HT1080 cells, interacts with the cyclic RGD peptide. J. Biol. Chem. 267: 23159-23164, 1992.
35. Mecham, R.P. Receptors for laminin on mammalian cells. FASEB J. 5: 2538-2546, 1991.
36. Humphries, M.J. Olden, K. and Yamada, K.M. A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science (Washington DC), 233: 467-470, 1986.